Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

Levamisole-induced Vasculitis in a Cocaine User

EZRA HAHN and ISAAC I. BOGOCH
The Journal of Rheumatology October 2015, 42 (10) 1924-1925; DOI: https://doi.org/10.3899/jrheum.150027
EZRA HAHN
Department of Radiation Oncology, University of Toronto;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ISAAC I. BOGOCH
Staff Physician, Divisions of Internal Medicine and Infectious Diseases, University Health Network, Assistant Professor, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: isaac.bogoch{at}uhn.ca
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

A 50-year-old woman presented with a 3-day history of a progressive, painful, non-blanchable, purpuric rash (retiform purpura) with areas of necrosis and bullae formation involving her face, trunk, extremities, and oral and nasal mucosa (Figure 1). She endorsed a history of cocaine use, and urine toxicology screening was positive for both cocaine and levamisole by liquid chromatography-tandem mass spectrometry. Laboratory findings included leukopenia and an elevated erythrocyte sedimentation rate (67 mm/h). Antinuclear antibody and antineutrophil cytoplasmic antibody (ANCA) testing was positive with elevated antimyeloperoxidase and antiproteinase 3. An anticardiolipin antibody assay was negative.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Retiform purpura with surrounding erythema and areas of central necrosis and bullous formation on the legs (A) and on the helix of the right ear (B). These cutaneous findings, in particular on the helix of the ear, are characteristic of levamisole-induced vasculitis.

She was diagnosed with levamisole-induced vasculitis given the typical features of diffuse purpuric lesions (including the helical rims of the ears) and associated ANCA positivity in the appropriate epidemiologic context1,2. Intravenous dexamethasone (4 mg/day for 7 days) was initiated, which halted progression of skin lesions. She was transferred to a burn unit where she received surgical debridement of the necrotic tissue and skin grafting.

Levamisole, a common diluent used in the preparation of powder and crack cocaine, is thought to augment cocaine’s pleasurable “high”3. Levamisole is an immune modulator and anthelmintic agent that was removed from several national markets because of toxicities such as vasculitis and leukopenia3,4.

Optimal treatments for this condition remain to be elucidated, but drug cessation, supportive care, steroids, plasmapheresis, and surgical debridement are described3,4,5. Use of cocaine adulterated with levamisole has markedly increased in the past few years and levamisole-induced vasculitis should be considered in anyone presenting with leukopenia, retiform purpura, and a history of cocaine use3,4,5.

REFERENCES

  1. 1.↵
    1. Pendergraft WF 3rd,
    2. Niles JL
    . Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 2014;26:42–9.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Rongioletti F,
    2. Ghio L,
    3. Ginevri F,
    4. Bleidl D,
    5. Rinaldi S,
    6. Edefonti A,
    7. et al.
    Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948–51.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Pavenski K,
    2. Vandenberghe H,
    3. Jakubovic H,
    4. Adam DN,
    5. Garvey B,
    6. Streutker CJ
    . Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine users. J Cutan Med Surg 2013;17:123–8.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Graf J
    . Rheumatic manifestations of cocaine use. Curr Opin Rheumatol 2013;25:50–5.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Arora NP
    . Cutaneous vasculopathy and neutropenia associated with levamisole-adulterated cocaine. Am J Med Sci 2013;345:45–51.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 10
1 Oct 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Levamisole-induced Vasculitis in a Cocaine User
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Levamisole-induced Vasculitis in a Cocaine User
EZRA HAHN, ISAAC I. BOGOCH
The Journal of Rheumatology Oct 2015, 42 (10) 1924-1925; DOI: 10.3899/jrheum.150027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Levamisole-induced Vasculitis in a Cocaine User
EZRA HAHN, ISAAC I. BOGOCH
The Journal of Rheumatology Oct 2015, 42 (10) 1924-1925; DOI: 10.3899/jrheum.150027
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Multiple Hematoma, Purpura, and Ulcers in a Patient With Rheumatoid Arthritis
  • Crystalline Deposition in a Nose With a Sinus Tract
  • Bone Erosion Repair With a Janus Kinase Inhibitor
Show more Images in Rheumatology

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire